Evidence map›Paper›PMID 30159100›Full record

ArticleBehavioural neurology2018

Histone Deacetylase Inhibitor Scriptaid Alleviated Neurological Dysfunction after Experimental Intracerebral Hemorrhage in Mice.

Heng Yang, Wei Ni, Hanqiang Jiang, Yu Lei, Jiabin Su, Yuxiang Gu, Liangfu Zhou

Open access · goldAbstract read
In one paragraph

Article in Behavioural neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Epigenetic mechanisms and potential therapeutic targets in stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. HDAC inhibition reduces white matter injury after intracerebral hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Heng YangDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Wei NiDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Hanqiang JiangDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Yu LeiDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Jiabin SuDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Yuxiang GuDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Liangfu ZhouDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.ORCID 0000-0001-6808-7120
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the role of Scriptaid in reducing brain injury after intracerebral hemorrhage (ICH) in mice.

methodsAn ICH model was constructed by injecting autologous blood into the right basal ganglia in mice. The animals were administered 3.5 mg/kg of Scriptaid intraperitoneally after ICH. The hematoma volume and hemoglobin level were measured to examine hematoma resolution. A behavior test and brain edema and white matter injury examinations indicated brain injury after ICH.

resultsScriptaid treatment promoted hematoma resolution and reduced the hematoma volume 7 d after ICH compared with the vehicle group (

conclusionsScriptaid can protect against brain injury after ICH and may be considered a new medical therapy method for ICH.

Indexed as

AnimalsBasal GangliaBrainBrain EdemaBrain InjuriesCerebral HemorrhageDisease Models, AnimalHematomaHistone Deacetylase InhibitorsHydroxylaminesMaleMiceMice, Inbred C57BLQuinolinesHistone Deacetylase InhibitorsHydroxylaminesQuinolinesscriptaid

Identifiers

PMID30159100
PMCPMC6109529
OpenAlexW2886881624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.